Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
NEW YORK, Oct 13 (Reuters) — Martin Shkreli has violated a lifetime ban from the pharmaceutical industry by trading stocks and discussing his opinions about companies in the industry, federal and state regulators said on Tuesday. In a court filing, the Federal Trade Commission and a coalition of seven states asked US D
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
The FTC and states say Shkreli violated a lifetime ban on participating in the pharmaceutical industry in a contempt claim.